Min Yang

Vice President

Min Yang

Boston

Education

Ph.D. and M.S., health outcomes and pharmacy practice, University of Texas at Austin; M.D., clinical medicine, Suzhou Medical College

Summary of Experience

Dr. Yang specializes in health economics and outcomes research (HEOR). She works closely with pharmaceutical, biotech, and device companies to develop HEOR strategies. Dr. Yang also designs and conducts studies from pipeline product development through product launch, post-market research, and biosimilar evaluation. She has extensive experience with clinical trial data, health insurance claims databases, electronic medical records, and primary surveys for evidence generation through both clinical trials and real-world data with conventional and innovative methodologies. Dr. Yang is an expert in clinical outcome assessments – such as patient-reported outcomes (PROs) and clinician-reported outcomes (ClinROs) – as well as health preference research. She has supported the development and validation of multiple PROs and ClinROs, as well as generated evidence for regulatory submission.

A frequent collaborator with academic experts and clinical key opinion leaders, Dr. Yang’s research has been published in many peer-reviewed journals and presented at numerous clinical and economic research conferences. In recognition for her work in women’s health, she has received the American College of Obstetricians and Gynecologists (ACOG)/Bayer Healthcare Pharmaceuticals Research Award. In addition to Dr. Yang’s HEOR credentials, she is a licensed oncology surgeon in China and a guest lecturer at the University of Texas at Austin College of Pharmacy. Prior to joining Analysis Group, Dr. Yang was a senior scientist at QualityMetric (now part of Optum, Inc.).

Selected Publishing